“Viagra for Women” on the British Market

For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.


A testosterone patch to increase the female sex drive went on the market this week in the UK. Intrinsa can be prescribed only to women who have had menopause or hysterectomies. Unlike Viagra, Intrinsa takes up to a few weeks to take effect. Intrinsa targets Female Sexual Dysfunction, which was only seven years ago officially recognized as a disorder.The UK’s Daily Mail predicts that Intrinsa will become a “lifestyle drug.” Salon worries Intrinsa will set up unreasonable expectations for the female libido. And I think that since the roots of Female Sexual Dysfunction are often social, not physiological, a designer drug may not be the best fix.

—Rose Miller

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest